DISCONTINUATION SYNDROME FOLLOWING CESSATION OF TREATMENT WITH CLONIDINE AND OTHER ANTIHYPERTENSIVE AGENTSWEBER MA.1980; J. CARDIOVASC. PHARMACOL.; USA; DA. 1980; VOL. 2; SUPPL. 1; PP. 73-89; BIBL. 97 REF.Article

SARALASIN TESTING FOR RENIN-DEPENDENT HYPERTENSIONWEBER MA.1979; ARCH. INTERN. MED.; USA; DA. 1979; VOL. 139; NO 1; PP. 93-95; BIBL. 10 REF.Article

A PHYSIOLOGICAL BASIS FOR THE TREATMENT OF ESSENTIAL HYPERTENSIONWEBER MA; LARAGH JH.1978; BULL. NEW YORK ACAD. MED.; USA; DA. 1978; VOL. 54; NO 10; PP. 931-943; BIBL. 17 REF.Article

THE SYMPATHETIC NERVOUS SYSTEM IN PRIMARY HYPERTENSIONWEBER MA; DRAYER JLM.1982; MINER. ELECTROLYTE METAB.; ISSN 0378-0392; CHE; DA. 1982; VOL. 7; NO 2; PP. 57-66; BIBL. 60 REF.Article

PRAZOSIN: PRELIMINARY REPORT AND COMPARATIVE STUDIES WITH OTHER ANTIHYPERTENSIVE AGENTS = PRAZOSINE: RAPPORT PRELIMINAIRE ET ETUDES COMPARATIVES AVEC D'AUTRES AGENTS ANTIHYPERTENSIFSSTOKES GS; WEBER MA.1974; BRIT. MED. J.; G.B.; DA. 1974; NO 5914; PP. 298-300; BIBL. 5 REF.Article

CATECHOLAMINE-MEDIATED CONSTRICTOR EFFECTS OF ALDOSTERONE ON VASCULAR SMOOTH MUSCLEWEBER MA; PURDY RE.1982; LIFE SCIENCES(1973; ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 23; PP. 2009-2017; BIBL. 43 REF.Article

BP AS A DETERMINANT OF CARDIAC LEFT VENTRICULAR MUSCLE MASSDRAYER JIM; WEBER MA; DEYOUNG JL et al.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 1; PP. 90-92; BIBL. 9 REF.Article

CARDIAC MUSCLE MASS DURING VASODILATATION THERAPY OF HYPERTENSIONDRAYER JIM; GARDIN JM; WEBER MA et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 19; NO 6; PP. 727-732; BIBL. 19 REF.Article

CHANGES IN VENTRICULAR SEPTAL THICKNESS DURING DIURETIC THERAPYDRAYER JIM; GARDIN JM; WEBER MA et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 3; PP. 283-288; BIBL. 20 REF.Article

LOW AND HIGH RENIN ESSENTIAL HYPERTENSION: A COMPARISON OF CLINICAL AND BIOCHEMICAL CHARACTERISTICSDRAYER JIM; WEBER MA; SEALEY JE et al.1981; AM. J. MED. SCI.; ISSN 0002-9629; USA; DA. 1981; VOL. 281; NO 3; PP. 135-142; BIBL. 24 REF.Article

THE POSSIBLE IMPORTANCE OF ALDOSTERONE AS WELL AS RENIN IN THE LONG-TERM ANTIHYPERTENSIVE ACTION OF PROPRANOLOL.DRAYER JIM; WEBER MA; LONGWORTH DL et al.1978; AMER. J. MED.; U.S.A.; DA. 1978; VOL. 64; NO 2; PP. 187-192; BIBL. 16 REF.Article

DISPARATE PATTERNS OF ALDOSTERONE RESPONSE DURING DIURETIC TREATMENT OF HYPERTENSION.WEBER MA; DRAYER JIM; REV A et al.1977; ANN. INTERN. MED.; U.S.A.; DA. 1977; VOL. 87; NO 5; PP. 558-563; BIBL. 34 REF.Article

PHENTOLAMINE TESTING FOR ALPHA ADRENERGIC PARTICIPATION IN HYPERTENSIVE PATIENTS: INDEPENDENCE FROM RENIN PROFILES.DRAYER JIM; WEBER MA; ATLAS SA et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 3; PP. 286-292; BIBL. 1 P. 1/2Article

LONG-TERM BP MONITORING IN THE EVALUATION OF ANTIHYPERTENSIVE THERAPYDRAYER JIM; WEBER MA; DEYOUNG JL et al.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 5; PP. 898-901; BIBL. 12 REF.Article

CENTRALLY ACTING ANTIHYPERTENSIVE AGENTS: A COMPARISON OF LOFEXIDINE WITH CLONIDINESCHULTZ HS; CHRETIEN SD; BREWER DD et al.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 2; PP. 65-71; BIBL. 15 REF.Article

THE ALEMPT DISCONTINUATION OF ANTIHYPERTENSINE TREATMENTGARBUS SB; WEBER MA; PRIEST RJ et al.1979; J. CLIN. PHARMACOL.; USA; DA. 1979; VOL. 19; NO 8-9 PART. 1; PP. 476-486; BIBL. 65 REF.Article

A REPRESENTATIVE VALUE FOR WHOLE-DAY BP MONITORINGWEBER MA; DRAYER JIM; WYLE FA et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 248; NO 13; PP. 1626-1628; BIBL. 8 REF.Article

LOW-DOSE DIURETIC AND BETA ADRENOCEPTOR BLOCKER IN ESSENTIAL HYPERTENSIONWEBER MA; PRIEST RT; RICCI BA et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 2; PP. 149-158; BIBL. 58 REF.Article

ACUTE REVERSIBLE RENAL IMPAIRMENT PRODUCED BY A URICOSURIC DIURETICHUBBELL FA; WEBER MA; MEGAFFIN BB et al.1980; WEST. J. MED.; ISSN 0093-0415; USA; DA. 1980; VOL. 133; NO 5; PP. 444-446; BIBL. 6 REF.Article

EFFECTS OF SODIUM DEPLETION ON PLASMA RENIN ACTIVITY AND ON THE URINARY EXCRETION OF CYCLIC AMP AND ALDOSTERONE IN HYPOPARATHYROID PATIENTS = EFFETS D'UNE CARENCE EN SODIUM SUR L'ACTIVITE DE LA RENINE PLASMATIQUE ET SUR L'EXCRETION URINAIRE D'AMP CYCLIQUE ET D'ALDOSTERONE CHEZ DES SUJETS HYPOPARATHYROIDIENSWEBER MA; KLEEREKOPER M; THORNELL IR et al.1975; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1975; VOL. 40; NO 6; PP. 982-987; BIBL. 26REF.Article

DIFFERENTIAL EFFECTS OF DIURESIS AND BETA-ADRENORECEPTOR BLOCKADE DURING ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN PATIENTS WITH SEVERE HYPERTENSIONDRAYER JIM; WEBER MA; LIPSON JL et al.1982; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1982; VOL. 22; NO 4; PP. 179-186; BIBL. 17 REF.Article

PHARMACOLOGICAL STIMULATION OF RENIN SECRETION WITHIN THE KIDNEY.WEBER MA; GRAHAM RM; GAIN JM et al.1977; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1977; VOL. 227; NO 2; PP. 343-350; BIBL. 27 REF.Article

RENIN AND ALDOSTERONE SUPPRESSION IN THE ANTIHYPERTENSIVE ACTION OF CLONIDINE.WEBER MA; CASE DB; BAER L et al.1976; AMER. J. CARDIOL.; U.S.A.; DA. 1976; VOL. 38; NO 6; PP. 825-830; BIBL. 25 REF.Article

DIAZOXIDE-INDUCED RENIN RELEASE IN DIAGNOSIS OF REMEDIABLE RENOVASCULAR HYPERTENSIONSTOKES GS; WEBER MA; GAIN J et al.1976; AUSTRAL. NEW ZEAL. J. MED.; AUSTRAL.; DA. 1976; VOL. 6; NO 1; PP. 26-29; BIBL. 13 REF.Article

A ROLE FOR RENIN IN REBOUND HYPERTENSION AND ENCEPHALOPATHY AFTER INFUSION OF SARALASIN ACETATE (SAR¹-ALA⁸-ANGIOTENSIN II).KEIM HJ; DRAYER JI; CASE DB et al.1976; NEW ENGL. J. MED.; U.S.A.; DA. 1976; VOL. 295; NO 21; PP. 1175-1177; BIBL. 9 REF.Article